AMICUS THERAPEUTICS, INC. — Director's Dealing 2012

Aug 30, 2012

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: AMICUS THERAPEUTICS INC (FOLD)
CIK: 0001178879
Period of Report: 2012-08-29

Reporting Person: Winterbottom Joan (SVP, Human Resources)

Holdings (Derivative)

Security	Exercise Price	Expiration	Underlying	Shares	Ownership
Stock Options (right to buy)	$5.01	2022-08-29	Common Stock (125000)		Direct

Footnotes

F1: These options vest and become exercisable in a series of installments. The first installment, which consists of 25% of the total aggregate number of options granted, vests on August 29, 2013. The remaining options vest and become exercisable in a series of thirty-five successive equal monthly installments, beginning on September 1, 2013, with the final installment vesting on August 29, 2016.